https://www.targetedonc.com/view/molecular-subtyping-leads-to-new-targeted-trials-in-endometrial-cancer
0
0
9/11/23 at 5:37pm
Organization
Targetedonc.com
30 words
0
Comments
Ruchi Garg, MD, discusses the impact of targeted therapies studies in patients with early and recurrent endometrial cancer.
You are the first to view
Create an account
or login to join the discussion